Press Release October 25, 2021Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age 0 0 Share
Company Ticker News October 25, 2021Moderna says its COVID-19 shot generates 'robust' response in children 6 to 11 0 0 Share
Company Ticker News October 25, 2021Moderna Says Its Covid Shot Generates ‘Strong' Immune Response In Kids Aged 6-11 0 0 Share
Company Ticker News October 25, 2021Moderna says its Covid vaccine generates strong immune response in 6- to 11-year-olds 0 0 Share
Company Ticker News October 23, 2021Deutsche Bank: Moderna shares could slide sharply to $250 0 0 Share
Company Ticker News October 22, 2021Moderna Stock Falls. Deutsche Bank Gives '‘Concept Stock' a Sell Rating. 0 0 Share